Problematic Promotion of Medications by Nurse Ambassadors—Legal and Ethical Issues

Abstract: In August 2020, the pharmaceutical company AbbVie agreed to pay California $24 million to settle a whistleblower case that involved its nurse ambassador program for adalimumab (Humira), while not admitting any wrongdoing.